Page last updated: 2024-09-04
bz-423 and Hyperplasia
bz-423 has been researched along with Hyperplasia in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bhagavathula, N; Boitano, AE; Fay, K; Glick, GD; Johnson, K; Kang, S; Nerusu, KC; Opipari, AW; Sherzer, H; Varani, J | 1 |
Other Studies
1 other study(ies) available for bz-423 and Hyperplasia
| Article | Year |
|---|---|
A novel benzodiazepine selectively inhibits keratinocyte proliferation and reduces retinoid-induced epidermal hyperplasia in organ-cultured human skin.
Topics: Autocrine Communication; Benzodiazepines; Cell Proliferation; Cell Survival; ErbB Receptors; Fibroblasts; Humans; Hyperplasia; Immunoblotting; Indicators and Reagents; Keratinocytes; Mitogen-Activated Protein Kinase Kinases; Organ Culture Techniques; Paracrine Communication; Phosphorylation; Reactive Oxygen Species; Retinoids; Signal Transduction; Skin | 2005 |